MEMORANDUM OPINION AND ORDER
For the following reasons, the Court grants in part and denies in part Plaintiff Sloan Valve Company’s (“Sloan”) Motions Under Rule 12.
BACKGROUND
Sloan filed its complaint against Defendants Zurn Industries, Inc. and Zurn Industries, LLC (collectively “Zurn”) on January 13, 2010 alleging infringement of U.S. Patent No. 7,607,635 entitled “Flush Valve Handle Assembly Providing Dual Mode Operation” (the “'635 Patent”) and the corresponding U.S. Patent Application Publication No. 2006/015729 (the “'729 Patent Application”). (R. 1-1, Complaint, ¶ 1.)
I. Sloan’s Complaint
Sloan’s complaint contains the following allegations. Sloan is a leading manufacturer of plumbing products. Id. at ¶ 7. In 2004, John Wilson, an engineer working in Sloan’s research and development group, conceived a new dual flush valve and handle assembly that would distribute one amount of water when pushed down, and a reduced quantity of water when lifted up. Id. at ¶ 11. Sloan recognized Wilson’s invention as a solution to satisfy the need for a dual mode flush product for commercial application and accordingly decided to invest in testing, developing and commercial *747 izing Wilson’s invention. Id. at ¶¶ 11-12. After testing a number of experimental handle assemblies, Sloan announced the commercial introduction of the product on August 1, 2005. Id. at ¶¶ 13, 16. On August 4, 2005, Zurn announced a water-saving valve and handle assembly that, upon information and belief, Zurn derived by copying Sloan’s dual mode flush handle. Id. at ¶¶ 18-22.
Sloan filed a patent application in the United States Patent and Trademark Office (“U.S. Patent Office”) claiming the unique features of the dual mode flush handle assembly and valves. Id. at ¶ 23. On July 13, 2006, the U.S. Patent Office published Sloan’s patent application as the '729 Patent Application. Id. at ¶ 24. On October 27, 2009, after finding Wilson’s invention patentable, the U.S. Patent Office issued the '635 Patent.
Count I of Sloan’s complaint alleges that Zurn’s making, using, offering to sell, importing or selling dual mode handle assemblies and flush valves infringe Claims 1, 4-6, 10-12, 14, 19, 28-31 and 33-34 of the '635 Patent. Id. at ¶ 36. Count II of Sloan’s complaint alleges that Zurn infringed the '729 Patent Application by making, using, or offering for sale the invention in at least Claims 10-11, 15 and 31 of the '635 Patent between the publication of the '729 Patent Application and the issuance of the '635 Patent. Id. at ¶¶ 40-43. Sloan’s complaint also alleges claims against Zurn for inducement to infringe the '635 Patent and contributory infringement of the '635 Patent.
II. Zurn’s Answer, Counterclaim and Affirmative Defenses
On February 2, 2010, Zurn filed its Answer, Counterclaims, and Affirmative Defenses to Sloan’s complaint. (R. 17-1, Zurn’s Answer, Counterclaims, and Affirmative Defenses.) In its counterclaim, Zurn seeks a declaration of invalidity (Count I) and non-infringement (Count II) of all of the claims of the '635 Patent, and unenforceability of the '635 Patent due to inequitable conduct (Count III). Zurn also filed seven affirmative defenses which assert: (i) detrimental reliance, (ii) lack of actual notice of the '729 Patent Application, (iii) denial of infringement of any valid claim of the '635 Patent, (iv) estoppel, (v) invalidity and unenforceability of the '635 Patent, (vi) misuse/unclean hands, and (vii) entitlement to attorneys’ fees.
Zurn’s claim of inequitable conduct contained in Count III of its counterclaim derives from statements made by Sloan during a reexamination that Sloan failed to disclose to the United States Patent Office during the prosecution of the '635 Patent. On May 11, 2009 and July 10, 2009, Sloan filed a(i) Request for Reexamination of United States Patent No. 7,481,413 (the “'413 Patent”) and (ii) Corrected Request for Reexamination of the '413 Patent (collectively “Request for Reexamination of the '413 Patent”). Id. at ¶¶ 15-16. Zurn alleges that Sloan made statements concerning prior art in the Request for Reexamination of the '413 Patent that are inconsistent with the specifications of the '729 Patent Application and the '635 Patent.
Specifically, in the Request for Reexamination of the '413 Patent, Sloan described U.S. Patent No. 1, 912,937 and stated that, “[t]he bore is inherently larger than the plunger so as to allow the plunger to passes [sic] there through. One of ordinary skill would understand the bore to be sized sufficiently larger than the plunger so as to avoid excessive frictional forces that would cause operation to be difficult and that would result in greater amount of operational wear.” Id. at ¶ 20. The '635 Patent and the '729 Patent Application state that, “[y]et another possible alternate construction of the bushing passage is to *748 make the inside diameter of the bushing passage appreciably larger than the outside diameter of the plunger.” Id. at ¶ 22. Zurn alleges that in the Request for Reexamination of the '413 Patent, Sloan argued that a plunger having a smaller radius than the inside diameter of the bushing was inherently taught by prior art references, and that in the specifications and claims of the '635 Patent Sloan stated that part of its invention included a plunger having a smaller radius that the inside diameter of the bushing. Id. at ¶¶ 24-25.
Zurn thus alleges that at least one claim in the '635 Patent covers a plunger having a smaller radius than the inside diameter of the bushing which is inherently taught by prior art references. Id. at ¶ 26. Zurn further alleges that Sloan did not disclose the Request for Reexamination of the '413 Patent to the United States Patent Office during the prosecution of the '635 Patent, and that it willfully did not advise the United States Patent Office that prior art inherently taught a plunger having a smaller radius than the inside diameter of the bushing. Id. at ¶ 29. Finally, Zurn alleges that the United States Patent Office would have considered this teaching and Sloan’s statements material to the examination of the '635 Patent.
LEGAL STANDARD
I. 12(b)(1) Motion to Dismiss
The standard of review for a Rule 12(b)(1) motion to dismiss for lack of subject matter jurisdiction depends on the purpose of the motion.
See United Phosphorus, Ltd. v. Angus Chem. Co.,
II. 12(b)(6) Motion to Dismiss
“A motion under Rule 12(b)(6) challenges the sufficiency of the complaint to state a claim upon which relief may be granted.”
Hallinan v. Fraternal Order of Police of Chicago Lodge No. 7,
III. Motion to Strike Affirmative Defenses
Rule 12(f) governs motions to strike. Pursuant to that Rule, the Court can strike “any insufficient defense or any redundant, immaterial, impertinent, or scandalous matter.” Fed.R.Civ.P. 12(f). “Affirmative defenses will be stricken ‘only when they are insufficient on the face of the pleadings.’ ”
Williams v. Jader Fuel Co.,
Courts in this Circuit apply a three-part test to affirmative defenses subject to a motion to strike: “(1) the matter must be properly pleaded as an affirmative defense; (2) the matter must be adequately pleaded under the requirements of Federal Rules of Civil Procedure 8 and 9; and (3) the matter must withstand a Rule 12(b) (6) challenge — in other words, if it is impossible for defendants to prove a set of facts in support of the affirmative defense that would defeat the complaint, the matter must be stricken as legally insufficient.”
Davis,
ANALYSIS
In its motion to dismiss, Sloan requests that the Court: (i) dismiss counts I and II of Zurn’s counterclaim with respect to the unasserted claims of Patent '635 pursuant to Federal Rule of Civil Procedure 12(b)(1) for lack of subject matter jurisdiction, (ii) dismiss Count III of Zurn’s counterclaim pursuant to Federal Rule of Civil Procedure 12(b)(6), and (iii) strike Zurn’s First, Second, Third, Sixth and Seventh affirmative defenses. For the following reasons, the Court grants in part and denies in part Zurn’s motion.
*750 I. Rule 12(b)(1) Motion to Dismiss Counts I and II of Zurn’s Counterclaim as They Relate to the Unasserted Claims
In its complaint, Sloan alleges that Znrn infringed 17 of the 25 claims of the '635 Patent: Claims 1, 2-6, 7-8, 10-12, 14, 19, 28-31 and 33-34. In counts I and II of its counterclaim, Zurn seeks a declaration of invalidity and non-infringement of all of the claims of the '635 Patent. Sloan argues that because its complaint only asserts infringement of certain claims, Zurn has failed to demonstrate that a justiciable controversy exists with respect to the unasserted claims of Patent '635. Accordingly, Sloan asserts that Counts I and II of Sloan’s counterclaim must be dismissed pursuant to Rule 12(b)(1) with respect to the unasserted claims because the Court lacks subject matter jurisdiction over those claims.
The Declaratory Judgment Act provides, in relevant part:
In a case of actual controversy within its jurisdiction, ... any court of the United States, upon the filing of an appropriate pleading, may declare the rights and other legal relations of any interested party seeking such declaration, whether or not further relief is or could be sought. Any such declaration shall have the force and effect of a final judgment or decree and shall be reviewable as such.
28 U.S.C. § 2201(a). In
MedImmune, Inc. v. Genentech, Inc.,
This case presents a unique question of justiciability because Sloan has only asserted infringement of certain claims of the 635 patent. In
Jervis B. Webb Co. v. Southern Systems, Inc.,
In order to withstand a 12(b)(1) motion to dismiss, Zurn must demonstrate that it is able to meet the case or controversy requirements set forth in
Medlmmune
with respect to the unasserted claims in the '635 Patent. Zurn makes two arguments in this regard. First, Zurn asserts that it has an immediate apprehension of suit on two of the unasserted claims, claims 9 and 18, because these claims depend from either claim 10-11 or 19. This conclusory statement, however, is insufficient to establish a “substantial controversy” between the parties.
See MedImmune,
Second, Zurn argues that because it has asserted an inequitable conduct claim, each and every claim of the '635 Patent is subject to the Court’s jurisdiction. While a court’s determination of inequitable conduct in relation to one or more claims of a patent renders the entire patent unenforceable,
Praxair, Inc. v. ATMI, Inc.,
Although the one remaining case cited by Cadbury, Flakice Corp. v. Liquid Freeze Corp.,131 F.Supp. 599 , 600 (D.Cal.1955), did involve an assertion of less than all of the patent’s claims, I agree with Wrigley that it is distinguishable on its facts. In Flakice, the court noted that the controversy revolved around the manufacture and sale of an ice machine as a whole, not just the part of the machine covered by a single claim in the plaintiffs patent. Id. Here, Wrigley is not disputing Cadbury’s right to manufacture and sell gum in general but, instead, challenges only the manufacture and sale of gum that contains cooling agents purportedly falling within the scope of Claim 34 of the '233 patent. I do not think the claims here establish the type of over-arching controversy that was at the heart of the court’s grant of declaratory judgment jurisdiction in Flakice.
Wm. Wrigley Jr. Co.,
Moreover, the analysis of other district courts that have held that an assertion of inequitable conduct does not necessarily give rise to jurisdiction over unasserted claims is persuasive. Relying on
Biogen, Inc. v. Amgen, Inc.,
In Biogen, the court held that “in light of [the patent holder’s] latest representation that it will relinquish forever the right to sue [defendant] on any claims other than [the asserted claims], [defendant’s] counterclaim will be dismissed.” The court noted, however, that “[a] finding of nonjurisdiction over the counterclaim [for invalidity of non-asserted claims] does not ... preclude [defen *753 dant] from contesting the enforceability of the 702 patent.” Id. at 38 (citing Scripps Clinic and Research Foundation v. Genentech Inc.,707 F.Supp. 1547 , 1557 n. 15 (N.D.Cal.1989), rev’d on other grounds,927 F.2d 1565 (Fed.Cir.1991) (“[A] determination that inequitable conduct has occurred renders the ‘entire patent’ unenforceable. However, ... this Court has jurisdiction only over those claims with respect to which infringement is alleged.”)). The Biogen court noted that “[t]he reason that a conservative approach to jurisdiction is not unfair lies in the significant difference between a claim of unenforceability and a claim of invalidity. An inequitable conduct defense is directed to the former, and is not dependent on the ability to litigate the latter.” Id. (citing Jervis B. Webb Co. v. Southern Sys., Inc.,742 F.2d 1388 , 1400 n. 8 (Fed.Cir.1984) (noting that “when the proof at trial establishes ... fraud,” a court declining declaratory judgment jurisdiction over nonasserted claims may nonetheless enter “a declaratory judgment that all claims are invalid.”)).
Amgen, Inc. v. ARIAD Phams., Inc.,
For these reasons, Zurn has failed to demonstrate that a justiciable controversy exists with respect to the unasserted claims of the '635 Patent. The Court accordingly grants Sloan’s Rule 12(b)(1) motion to dismiss Counts I and II of Zurn’s counterclaim as they relate to the unasserted claims without prejudice.
II. Rule 12(b)(6) Motion to Dismiss Count III of Zurn’s Counterclaim
Sloan also asserts that the Court should dismiss Count III of Zurn’s counterclaim alleging inequitable conduct pursuant to Rule 12(b)(6). Specifically, Sloan asserts that Zurn’s counterclaim alleging inequitable conduct fails to meet the requirements for materiality set forth in 37 C.F.R. § 1.56. 37 C.F.R. § 1.56(a) provides that “[e]ach individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the [PTO], which includes a duty to disclose to the [PTO] all information known to that individual to be material to patentability....” 37 C.F.R. § 1.56(b) further provides that:
Information is material when: it is not cumulative to information already of record or being made of record in the application, and
(1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or
(2) It refutes, or is inconsistent with, a position the applicant takes in:
(i) Opposing an argument of unpatentability relied on by the Office, or
(ii) Asserting an argument of patentability.
37 C.F.R. § 1.56(b). Sloan focuses the arguments in both its memorandum in support of its motion to dismiss and its reply brief on Zurn’s alleged failure to plead materiality as required by 37 C.F.R. § 1.56. (R. 25-1, Sloan’s Memorandum in Support of Its Rule 12 Motions, p. 8) (“The failure to plead and inability to prove any facts that would support either of the requirements for Patent Office Rule 56 establishing materiality is fatal to Count II”); (R. 45-1, Sloan’s Reply Memorandum in Support of Rule 12 Motions, p. 6) (“To plead materiality based on Rule 56(b)(1), Zurn’s pleadings would need to allege fac *754 tual bases that the information in Sloan’s attorney’s argument in the reexamination ... ”). The Federal Circuit, however, distinguishes between the materiality test set forth by the U.S Patent Office in 37 C.F.R. § 1.56 and other tests for materiality established by the Federal Circuit:
The Federal Circuit provides several, alternative tests for materiality. Digital Control Inc. v. Charles Mach. Works,437 F.3d 1309 , 1316 (Fed.Cir.2006). The main test ... is whether a reasonable examiner would have considered such prior art important in deciding whether to allow the patent application. Id. at 1314. The more recent and narrow materiality test based on the PTO’s Rule 56 enacted in 1992, provides that information is material when it is not cumulative to information already of record or being made of record in the application, and (1) establishes a prima facie case of unpatentability, where the information compels a conclusion that a claim in unpatentable under a preponderance of the evidence and giving the broadest reasonable construction consistent with the specification to each term; or (2) refutes or is inconsistent with a position that the applicant takes in opposing an argument of unpatentability relied on by the PTO or in asserting an argument of patentability. 37 C.F.R. § 1.56(b); Purdue Pharma, L.P. v. Endo Phanns., Inc.,438 F.3d 1123 , 1129 (Fed.Cir.2006).
Chatsworth Prods., Inc. v. Panduit Corp.,
Indeed, in its response brief, Zurn cites to the broader materiality test espoused by the Federal Circuit which provides that, “[t]he materiality of information withheld during prosecution may be judged by the ‘reasonable examiner’ standard. That is, ‘[m]ateriality ... embraces any information that a reasonable examiner would substantially likely consider important in deciding whether to allow an application to issue as a patent.’ ”
McKesson Info. Solutions, Inc. v. Bridge Med., Inc.,
*755 III. Motion to Strike Zurn’s Affirmative Defenses
Sloan next requests the Court to strike Zurris First, Second, Third, Sixth and Seventh affirmative defenses. The Court will address each of the contested affirmative defenses in turn.
Zurris first and sixth affirmative defenses are insufficiently pleaded. Zurn’s first affirmative defense alleges estoppel in a single sentence: “Zurn has detrimentally relied upon Sloan’s acquiescence with respect to Zurn acts alleged to infringe the '729 Patent Application and the '635 Patent and Sloan is therefore estopped from seeking the relief requested in Sloan’s Complaint.” (R. 17-1, Zurris Answer, Counterclaims and Affirmative Defenses, p. 5, ¶ 54.) Zurn’s sixth affirmative defense alleges that “[u]pon information and belief, Plaintiff is barred in whole or in part from asserting the '635 patent.”
Id.
at ¶ 61. Because they are subject to federal pleading requirements affirmative defenses “must set forth a ‘short and plain statement’ of all the material elements of the defense asserted; bare legal conclusions are not sufficient.”
Heller,
Zurris second affirmative defense alleges that: “Zurn did not have actual notice of the '729 Patent Application at the time it commenced the acts alleged to constitute infringement. Furthermore, Sloan did not provide Zurn with actual notice that Zurn infringed any of the claims of the '729 Patent Application or the '635 Patent.” (R. 17-1, Zurris Answer, Counterclaims and Affirmative Defenses, p. 5, ¶ 55.) While Sloan objects to the content of the affirmative defense, the defense must be stricken for the independent reason that it is not properly pleaded as an affirmative defense. Zurn has already denied the allegation contained in Sloan’s complaint that “Zurn had actual notice of the published '729 Patent Application at the time it committed the acts of infringement of the '729 Patent Application.”
Id.
at ¶ 43. Zurn’s second affirmative defense is accordingly not a proper Rule 8 defense, nor has Zurn identified any support to demonstrate that courts have recognized such an affirmative defense.
See Hayes v. Agilysys, Inc.,
*756
Zurn’s third and seventh affirmative defenses suffer from the defect that they are not actually affirmative defenses. “The concept of an affirmative defense under Rule 8(c) ‘requires a responding party to admit a complaint’s allegations but then permits the responding party to assert that for some legal reason it is nonetheless excused from liability (or perhaps from full liability).’ ”
Reis Robotics USA, Inc. v. Concept Indus.,
The Court accordingly grants Sloan’s motion to strike Zurn’s First, Second, Third, Sixth, and Seventh affirmative defenses.
CONCLUSION
For the foregoing reasons, the Court grants in part and denies in part Sloan’s Motions Under Rule 12. Zurn is ordered to file an amended counterclaim and affirmative defenses consistent with this ruling by May 18, 2010.
Notes
. Zurn incorrectly asserts that in
Jervis
the Federal Circuit held that "even though claims 4 and 8 were not asserted, since claim 9 was asserted, and claim 9 depends from claims 4 and 8, a case or controversy existed as to claims 4 and 8.” (R. 44-1, Defendant's Memorandum in Opp’n to Plaintiff's Motions Under Rule 12, p. 9.) Instead, in
Jervis,
the court noted that the plaintiff had litigated the dependent claims by relying on them in post-trial motions.
Jervis,
. Because Sloan only challenges Zurn's failure to plead that the relevant information is not cumulative to information of record pursuant to 37 C.F.R. § 1.56(b), the Court need not address Sloan’s argument in this regard. The Court notes however, that while "[Regardless which standard a court applies, withheld information that is merely cumulative to information already before the PTO is not material,”
Digital Control, Inc.,
